piribedil has been researched along with pergolide in 8 studies
Timeframe | Studies, this research(%) | All Research% |
---|---|---|
pre-1990 | 2 (25.00) | 18.7374 |
1990's | 0 (0.00) | 18.2507 |
2000's | 5 (62.50) | 29.6817 |
2010's | 1 (12.50) | 24.3611 |
2020's | 0 (0.00) | 2.80 |
Authors | Studies |
---|---|
Audinot, V; Boutin, JA; Cussac, D; Maiofiss, L; Millan, MJ; Newman-Tancredi, A | 1 |
Agid, Y; Dubois, B | 1 |
Burton, K; Calne, DB | 1 |
Ferreira, JJ; Galitzky, M; Montastruc, JL; Rascol, O | 1 |
Gekht, AB | 1 |
Goetz, CG; Poewe, W; Rascol, O; Sampaio, C | 1 |
Al-Fulaij, MA; Beinborn, M; Kopin, AS; Ren, Y | 1 |
Dupuis, N; Hanson, J; Laschet, C | 1 |
2 review(s) available for piribedil and pergolide
Article | Year |
---|---|
[Use of dopamine agonists in the treatment of Parkinson's disease].
Topics: Antiparkinson Agents; Benzothiazoles; Bromocriptine; Cabergoline; Controlled Clinical Trials as Topic; Dopamine Agonists; Ergolines; Humans; Indoles; Lisuride; Parkinson Disease; Pergolide; Piribedil; Placebos; Pramipexole; Serotonin Receptor Agonists; Thiazoles; Time Factors | 2002 |
Evidence-based medical review update: pharmacological and surgical treatments of Parkinson's disease: 2001 to 2004.
Topics: Amantadine; Antiparkinson Agents; Apomorphine; Benzophenones; Benzothiazoles; Bromocriptine; Cabergoline; Catechol O-Methyltransferase Inhibitors; Deep Brain Stimulation; Dihydroergocryptine; Ergolines; Fetal Tissue Transplantation; Globus Pallidus; Humans; Indans; Indoles; Levodopa; Lisuride; Mesencephalon; Monoamine Oxidase Inhibitors; Neurosurgical Procedures; Nitrophenols; Parkinson Disease; Pergolide; Piribedil; Pramipexole; Selegiline; Thiazoles; Tolcapone | 2005 |
6 other study(ies) available for piribedil and pergolide
Article | Year |
---|---|
Differential actions of antiparkinson agents at multiple classes of monoaminergic receptor. I. A multivariate analysis of the binding profiles of 14 drugs at 21 native and cloned human receptor subtypes.
Topics: Animals; Antiparkinson Agents; Binding Sites; Binding, Competitive; Cholinergic Antagonists; Cloning, Molecular; Cluster Analysis; Dopamine Agonists; Humans; Rats; Receptor, Muscarinic M1; Receptors, Adrenergic, alpha-1; Receptors, Adrenergic, alpha-2; Receptors, Adrenergic, beta; Receptors, Dopamine D1; Receptors, Dopamine D2; Receptors, Dopamine D3; Receptors, Histamine H1; Receptors, Muscarinic; Receptors, Neurotransmitter; Receptors, Serotonin | 2002 |
[Dopaminergic agonists in Parkinson disease].
Topics: Aged; Bromocriptine; Dopamine; Ergolines; Humans; Levodopa; Lisuride; Parkinson Disease; Pergolide; Piribedil | 1986 |
Dopamine agonists and Parkinson's disease.
Topics: Antiparkinson Agents; Apomorphine; Brain; Bromocriptine; Ergolines; Ergot Alkaloids; Humans; Levodopa; Lisuride; Neurons; Parkinson Disease; Pergolide; Piribedil; Receptors, Dopamine | 1984 |
Sleep attacks and Parkinson's disease treatment.
Topics: Accidents, Traffic; Aged; Antiparkinson Agents; Bromocriptine; Dopamine Agonists; Female; Humans; Lisuride; Male; Middle Aged; Narcolepsy; Parkinson Disease; Pergolide; Piribedil | 2000 |
Identification of amino acid determinants of dopamine 2 receptor synthetic agonist function.
Topics: Amino Acid Sequence; Amino Acid Substitution; Amino Acids; Animals; Binding Sites; Bromocriptine; Cell Line, Tumor; Dopamine Agonists; Drosophila; Humans; Indoles; Ligands; Luciferases; Molecular Sequence Data; Mutation; Pergolide; Piribedil; Receptors, Dopamine D2; Receptors, G-Protein-Coupled; Structure-Activity Relationship; Transfection | 2007 |
A dynamic and screening-compatible nanoluciferase-based complementation assay enables profiling of individual GPCR-G protein interactions.
Topics: Cells, Cultured; HEK293 Cells; Humans; Ligands; Luciferases; Nanoparticles; Pergolide; Piribedil; Receptors, G-Protein-Coupled | 2019 |